Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Nutide Ventures LLC is a venture capital firm founded in 2025 and headquartered in Redwood City, California. The firm focuses on creating and investing in biotech and healthtech companies, aiming to transform patient lives through innovative healthcare solutions. Nutide Ventures partners with entrepreneurs and researchers to accelerate innovations in healthcare, providing both capital and strategic guidance.
The firm operates with a small team of six professionals, combining expertise in biotech operations and investment. Nutide Ventures has a portfolio of four companies, including notable names like BioRevolution and Sift Biosciences. The firm emphasizes collaboration between industry and academia, addressing pressing medical needs through its investments.
Nutide Ventures is positioned to support companies at various stages of development, from pre-seed to Series A, and is actively engaged in the biotech and healthtech sectors. Their commitment to human-centered outcomes drives their investment strategy, making them a compelling partner for startups in these fields.
Nutide Ventures primarily invests in the biotech and healthtech sectors, with a strong emphasis on human-centered outcomes. The firm seeks to provide not only capital but also strategic guidance and operational support to companies addressing significant medical challenges. Their investment thesis revolves around cutting-edge biotech, novel therapeutics, and innovative health technologies, aiming to bridge the gap between industry and academia.
Investment stages range from pre-seed to Series A, with a focus on companies that are developing biotech platforms, therapeutics, AI-driven diagnostics, and patient engagement tools. Nutide Ventures looks for visionary entrepreneurs and pioneering researchers who are committed to transforming patient lives through their innovations. The firm’s approach includes a blend of financial investment and hands-on support, ensuring that portfolio companies have the resources they need to succeed.
Nutide Ventures has a focused portfolio of four companies, showcasing its commitment to the biotech and healthtech sectors. Notable portfolio companies include:
This portfolio reflects Nutide Ventures' strategy of investing in companies that are at the forefront of healthcare innovation, addressing critical medical needs and improving patient outcomes.
Thomas Butler - Co-Founder and Managing Partner. Thomas has a background as a biotech operator and has successfully founded and scaled clinical-stage biopharma companies. He is also the CEO of BioRevolution, indicating a hands-on approach to company building.
Thanaa Makdsi - Co-Founder and Managing Partner. Thanaa brings extensive experience in finance, investing, sell-side equity research, corporate development, and investor relations. She is connected to initiatives like 'No Patient Left Behind', showcasing her commitment to impactful healthcare.
Ravi Upasani - Focuses on IP Strategy, leveraging his expertise to protect and enhance the value of portfolio companies' intellectual property.
Johannes Voigt - Specializes in Computational Science, contributing technical expertise to support the development of innovative health technologies.
Sheldon Wang - Expert in Drug Design, providing insights into the development of novel therapeutics within the portfolio.
Sonali Upasani - Responsible for Communications & Investor Relations, ensuring effective communication between the firm and its stakeholders.
To pitch Nutide Ventures, founders should visit their website at nutideventures.com. The firm prefers detailed pitches that clearly outline the startup's mission, technology, and potential impact on patient outcomes. A well-structured deck that includes market analysis, competitive landscape, and financial projections is recommended.
Nutide Ventures does not specify a formal application process, but they encourage warm introductions through their network. Response times may vary, but founders can expect feedback on their pitches as the firm actively engages with promising startups.
In April 2026, Nutide Ventures participated in an oversubscribed $3.7 million pre-seed financing round for Sift Biosciences, which is advancing its next-generation T-cell immunotherapy platform. This investment highlights Nutide Ventures' active engagement in funding promising biotech innovations.
Since its founding in 2025, Nutide Ventures has been building a portfolio that reflects its commitment to supporting transformative healthcare solutions. The firm continues to seek out innovative companies in the biotech and healthtech sectors, aiming to address pressing medical needs.
What are Nutide Ventures' investment criteria?
Nutide Ventures invests in biotech and healthtech companies at various stages, primarily focusing on pre-seed to Series A. They look for companies that emphasize human-centered outcomes and are addressing significant medical challenges.
How can I pitch to Nutide Ventures?
Founders can pitch their ideas by visiting the Nutide Ventures website at nutideventures.com. The firm encourages entrepreneurs to provide detailed information about their innovations and how they aim to transform patient lives.
What makes Nutide Ventures different from other investors?
Nutide Ventures combines capital investment with strategic guidance and operational support. Their focus on human-centered outcomes and collaboration between entrepreneurs and researchers sets them apart in the biotech and healthtech investment landscape.
What is the geographic focus of Nutide Ventures?
Nutide Ventures primarily invests in North America, specifically within the United States, targeting innovative companies in the biotech and healthtech sectors.
What is the typical check size for Nutide Ventures?
While specific check sizes are not disclosed, Nutide Ventures invests across various stages, indicating flexibility in funding amounts based on the needs of the portfolio companies.
What kind of support do portfolio companies receive?
Nutide Ventures provides strategic guidance, operational support, and access to a strong network in the biotech and healthtech industries, helping portfolio companies accelerate their growth and innovation.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.